| scholarly article | Q13442814 |
| P2093 | author name string | Hidehiro Tajima | |
| Itasu Ninomiya | |||
| Katsunobu Oyama | |||
| Sachio Fushida | |||
| Takashi Fujimura | |||
| Tetsuo Ohta | |||
| Jun Kinoshita | |||
| Tomoya Tsukada | |||
| Shinichi Harada | |||
| Mitsuyoshi Okazaki | |||
| P2860 | cites work | Mesothelial cells differentiate into fibroblast-like cells under the scirrhous gastric cancer microenvironment and promote peritoneal carcinomatosis in vitro and in vivo | Q44539973 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 46-53 | |
| P577 | publication date | 2014-09-16 | |
| P1433 | published in | Cancer Letters | Q326372 |
| P1476 | title | The angiotensin II type 1 receptor blocker candesartan suppresses proliferation and fibrosis in gastric cancer | |
| P478 | volume | 355 |
| Q93088071 | 18 F-Labeled Derivatives of Irbesartan for Angiotensin II Receptor PET Imaging |
| Q104752919 | Angiotensin II receptor blockers valsartan and losartan improve survival rate clinically and suppress tumor growth via apoptosis related to PI3K/AKT signaling in nasopharyngeal carcinoma |
| Q37687136 | Angiotensin II type I receptor (AT1R) is an independent prognosticator of esophageal squamous cell carcinoma and promotes cells proliferation via mTOR activation |
| Q47107250 | Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest |
| Q47626689 | Angiotensin receptor blocker use and gastro-oesophageal cancer survival: a population-based cohort study. |
| Q36240916 | Establishing a xenograft mouse model of peritoneal dissemination of gastric cancer with organ invasion and fibrosis |
| Q47101405 | Importance of human peritoneal mesothelial cells in the progression, fibrosis, and control of gastric cancer: inhibition of growth and fibrosis by tranilast |
| Q64104170 | Influence of high glucose on mesangial cell-derived exosome composition, secretion and cell communication |
| Q58777726 | Low-dose eribulin mesylate exerts antitumor effects in gastric cancer by inhibiting fibrosis via the suppression of epithelial-mesenchymal transition and acts synergistically with 5-fluorouracil |
| Q35653603 | Marketed nonsteroidal anti-inflammatory agents, antihypertensives, and human immunodeficiency virus protease inhibitors: as-yet-unused weapons of the oncologists' arsenal |
| Q49987100 | Mechanisms of peritoneal dissemination in gastric cancer |
| Q57070174 | Multidisciplinary therapy for scirrhous gastric cancer: a retrospective analysis and proposal of new treatment strategy |
| Q33751263 | Neoadjuvant chemotherapy for pancreatic cancer: Effects on cancer tissue and novel perspectives |
| Q91691273 | Neoadjuvant chemotherapy with gemcitabine-based regimens improves the prognosis of node positive resectable pancreatic head cancer |
| Q26749570 | Osteopontin-A Master Regulator of Epithelial-Mesenchymal Transition |
| Q47863448 | Targeting the renin-angiotensin system to improve cancer treatment: Implications for immunotherapy. |
| Q47629815 | Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest |
| Q36110981 | The Impact of Angiotensin-Modulating Antihypertensives on Time Interval to Revision Surgery for Nasal Polyps |
| Q41851530 | The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKα/mTOR pathway in vitro and in vivo |
| Q90257740 | The effect of HIF-1α and PKM1 expression on acquisition of chemoresistance |
| Q92037020 | The role of the peritoneal microenvironment in the pathogenesis of colorectal peritoneal carcinomatosis |
| Q97075318 | Thrombospondin-1: A Key Protein That Induces Fibrosis in Diabetic Complications |
Search more.